Patents
Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
04/2009
04/02/2009WO2009039675A1 Macrocyclic lactones as fragrances
04/01/2009EP2042171A1 Therapeutic or prophylactic agent for allergic dermatitis
04/01/2009EP1664012B1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics
03/2009
03/26/2009WO2009015368A3 Multikinase inhibitors for use in the treatment of cancer
03/25/2009EP2039687A1 Therapeutic or prophylactic agent for multiple sclerosis
03/24/2009US7507831 Therapy for breast cancer; plant extracts; 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-epicatechin, 4-[(2-benzothiazolyl)thio]-5,7,3',4'-tetra-O-benzyl-catechin, 4-[(2-benzothiazolyl)thio]-3-O-acetyl-5,7,3',4'-tetra-O-benzyl-epicatechin
03/12/2009WO2008149244A3 Compositions and methods comprising analogues of radicicol a
03/12/2009US20090069413 Deuterium-enriched olopatadine
03/11/2009EP2033637A1 Therapeutic or prophylactic agent for leukemia
03/05/2009WO2008156817A8 Renin inhibitors
03/05/2009WO2008156816A8 Renin inhibitors
03/04/2009CN100465172C A macrolide compound of Macrolactin Q with antibacterial activity
02/2009
02/19/2009US20090048333 Zearalenone Macrolide Derivatives and Uses of the Same
02/05/2009US20090036691 Analogs of dicodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
02/04/2009CN100457748C Novel phenolic acid compounds of tanshin polyphenolic acid N and application thereof
01/2009
01/29/2009WO2009015368A2 Multikinase inhibitors for use in the treatment of cancer
01/29/2009WO2009015363A1 Zearalenone macrolide derivatives and uses of the same
01/29/2009US20090030032 Bicyclic Compound, Production and Use Thereof
01/29/2009CA2698271A1 Multikinase inhibitors for use in the treatment of cancer
01/15/2009WO2009008405A1 Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor
01/15/2009US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use
01/15/2009US20090018089 Crystalline forms of macrolide compounds endowed with antiinflammatory activity
01/15/2009CA2688459A1 Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor
01/14/2009EP2014655A2 Etnangien derivatives and their use as antibiotics
01/13/2009US7476647 1,5-dioxa-3-methyl-16-cyclohexadecanone; original odor characteristics, diffuses extremely well and is suitable for use as a fragrance, for example in cosmetic preparations, technical products or in alcoholic perfumery.
01/07/2009EP1687291A4 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
01/07/2009EP1204665B1 Chemokine receptor antagonists and methods of use therefor
01/01/2009US20090005579 Industrial scale; prepared via palladium acetate catalyst
12/2008
12/31/2008CN101333206A Macrolide compounds, preparation and application thereof
12/30/2008US7470797 Nuclear hormone receptor modulator; anticarcinogenic agent; 3-(4-Cyano-3-trifluoromethylphenylcarbamoyl containing 3-carboxy-14-dimethyl-5-oxa-7-oxybicyclo(2.2.2) heptane compound
12/30/2008US7470792 Process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
12/30/2008US7470719 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia a therosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof
12/25/2008US20080319049 Compounds For the Treatment of Metabolic Disorders
12/24/2008WO2008156817A2 Renin inhibitors
12/24/2008WO2008156816A2 Renin inhibitors
12/24/2008EP2004621A2 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
12/23/2008CA2306393C Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization
12/18/2008WO2008152001A1 METHOD FOR PRODUCING ε-CAPROLACTON
12/18/2008US20080311038 Radicicol Derivatives Useful for Position Emission Tomography
12/18/2008CA2690867A1 Process for preparing .epsilon.-caprolactone
12/17/2008EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/17/2008EP1716153A4 Methods, compositions, and apparatuses for forming macrocyclic compounds
12/17/2008EP1532131B1 Motilide compounds
12/11/2008US20080306259 Hydroxylation of beta-dicarbonyls with zirconium catalysts
12/04/2008WO2008148008A1 High throughput bioassay for identifying selective trka receptor agonists, and gambogic amide, a selective trka agonist with neuroprotective activity
12/04/2008WO2008147852A1 Kinesin inhibitors
12/04/2008US20080300134 Derivatives of Avermectin, Avermectin Monosaccharide and Avermectin Aglycone
12/03/2008EP1997816A1 Heterodiamondoids
12/03/2008EP1996571A2 Tetracyclic steroid derivatives useful as progesterone receptor modulators
12/03/2008EP1828087B1 Cyclopropanation process
12/03/2008CN100439375C Method of purifying moxidectin through crystallization
11/2008
11/27/2008WO2008142046A1 Etnangien derivatives and their use as antibiotics
11/27/2008WO2007133706A3 Antibiotic-bound poly (caprolactone) polymer
11/26/2008EP1994081A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
11/20/2008WO2008141130A1 Process for the preparation of epothilones
11/20/2008US20080287428 Novel Heterocyclidene Acetamide Derivative
11/19/2008CN101307045A Method for preparing caprolactone from cyclohexanone by catalytic oxidation
11/18/2008US7452915 Antiparasitic artemisinin derivatives (endoperoxides)
11/13/2008WO2008135488A1 Aspartyl protease inhibitors
11/06/2008WO2008133288A1 Tricyclic aryl compounds
11/06/2008US20080275256 Cyclopropanation Process
11/06/2008US20080275059 Novel physiologically active substances
10/2008
10/30/2008US20080269302 Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
10/28/2008US7442814 1-methoxy-2-phenyl ethenes useful for the preparation of 5-carboxaldehyde-2-3-dihydrobenzoxepines
10/22/2008CN101292162A Methods to identify therapeutic agents
10/21/2008US7439264 Therapeutic compounds
10/21/2008CA2296012C Epothilone derivatives
10/16/2008US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
10/09/2008WO2007086943A3 Wortmannin conjugates and uses thereof
10/09/2008US20080249255 polymerization of lactones in the presence of polymerization catalysts comprising transition metal hydrides, to form high molecular weight polylactones with low polydispersities, exhibiting improved mechanical properties
10/09/2008US20080249162 ATPase inhibitors; anticancer agents; synthesis and chemical intermediates thereto
10/08/2008EP1976843A2 Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
10/02/2008WO2008075048A3 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments
10/01/2008EP1420780B1 Cyclopropyl and cyclobutyl epothilone analogs
10/01/2008CN101277942A Cytotoxin compounds and methods of isolation
09/2008
09/25/2008WO2008113320A1 Lejimalid analoga and uses thereof
09/25/2008US20080234174 Furanoid and pyranoid c14-c18- oxabicycloalkanones as odoriferous and/or aroma substances
09/25/2008DE102007013765A1 Lejimalid Analoga und Verwendung davon Lejimalid analogues and use thereof
09/25/2008CA2681505A1 Iejimalid analoga and uses thereof
09/24/2008EP1971590A2 Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
09/18/2008WO2008110307A1 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
09/18/2008CA2679343A1 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
09/17/2008EP1968964A1 Radicicol derivatives useful for positron emission tomography
09/12/2008WO2008108420A1 Method for producing ε-caprolactone compound
09/12/2008WO2008108072A1 Method for producing ester or lactone
09/09/2008US7422676 Apparatus and process for the synthesis of hydrogen peroxide directly from hydrogen and oxygen
09/04/2008US20080214832 Process for making asenapine
08/2008
08/27/2008EP1961747A2 Borrelidin-producing polyketide synthase and its uses
08/21/2008WO2008099900A1 Process for production of dibenzoxepin compound
08/19/2008US7414157 Hydroxylation of β-dicarbonyls with zirconium catalysts
08/14/2008WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof
08/14/2008US20080194764 Fluorinated Cyclic Compound, Polymerizable Fluoromonomer, Fluoropolymer, Resist Material Comprising the Same, and Method of Forming Pattern with the Same
08/13/2008EP1956016A1 Bicyclic acyltryptophanols
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7410997 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs
08/12/2008CA2322158C Arylphenyl-substituted cyclic keto-enols
08/07/2008US20080188651 Analogs of dictyostatin, intermediates therefor and methods of systhesis thereof
08/06/2008CN100408582C Homocamptoth-ecine compounds, their preparation process and use
08/05/2008US7407975 Epothilone derivatives, method for producing same and their pharmaceutical use
07/2008
07/24/2008US20080177093 Use of an oxidopyrylium species as an intermediate in a chemical reaction; oxidopyrylium species is generated photochemically from a 3-hydroxychromone derivative followed by 1,3-dipolar cycloaddition of the oxidopyrylium species to a dipolarophile
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 36